Janus Kinase Inhibitors [MoA] - N0000190857

Pharmacologic Class Information

Pharmacologic Code N0000190857
Pharmacologic Name Janus Kinase Inhibitors
Pharmacologic Uses
  • Janus kinase (JAK) inhibitor
  • kinase inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Janus Kinase Inhibitors

The table contains 28 products whose active ingredient are classified under the same pharmacologic class Janus Kinase Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0002-4182Olumiant Non-Proprietary Name: BaricitinibTablet, Film CoatedOralEli Lilly And CompanyACTIVE
0002-4479Olumiant Non-Proprietary Name: BaricitinibTablet, Film CoatedOralEli Lilly And CompanyACTIVE
0002-4732Olumiant Non-Proprietary Name: BaricitinibTablet, Film CoatedOralEli Lilly And CompanyACTIVE
0002-6885Baricitinib Non-Proprietary Name: BaricitinibTablet, Film CoatedOralEli Lilly And CompanyACTIVE
0069-0235Cibinqo Non-Proprietary Name: AbrocitinibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncACTIVE
0069-0335Cibinqo Non-Proprietary Name: AbrocitinibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncACTIVE
0069-0435Cibinqo Non-Proprietary Name: AbrocitinibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncACTIVE
0069-0501Xeljanz XRNon-Proprietary Name: TofacitinibTablet, Film Coated, Extended ReleaseOralPfizer Laboratories Div Pfizer IncACTIVE
0069-0502Xeljanz XRNon-Proprietary Name: TofacitinibTablet, Film Coated, Extended ReleaseOralPfizer Laboratories Div Pfizer IncACTIVE
0069-1001Xeljanz Non-Proprietary Name: TofacitinibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncACTIVE
0069-1002Xeljanz Non-Proprietary Name: TofacitinibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncACTIVE
0069-1029Xeljanz Non-Proprietary Name: TofacitinibSolutionOralPfizer Laboratories Div Pfizer IncACTIVE
0074-1043Rinvoq Non-Proprietary Name: UpadacitinibTablet, Extended ReleaseOralAbbvie Inc.ACTIVE
0074-2306Rinvoq Non-Proprietary Name: UpadacitinibTablet, Extended ReleaseOralAbbvie Inc.ACTIVE
0074-2310Rinvoq Non-Proprietary Name: UpadacitinibTablet, Extended ReleaseOralAbbvie Inc.ACTIVE
50881-005Jakafi Non-Proprietary Name: RuxolitinibTabletOralIncyte CorporationACTIVE
50881-007Opzelura Non-Proprietary Name: RuxolitinibCreamTopicalIncyte CorporationACTIVE
50881-010Jakafi Non-Proprietary Name: RuxolitinibTabletOralIncyte CorporationACTIVE
50881-015Jakafi Non-Proprietary Name: RuxolitinibTabletOralIncyte CorporationACTIVE
50881-020Jakafi Non-Proprietary Name: RuxolitinibTabletOralIncyte CorporationACTIVE
50881-025Jakafi Non-Proprietary Name: RuxolitinibTabletOralIncyte CorporationACTIVE
63539-012Xeljanz Non-Proprietary Name: TofacitinibTablet, Film CoatedOralU.s. PharmaceuticalsACTIVE
63539-016Xeljanz Non-Proprietary Name: TofacitinibTablet, Film CoatedOralU.s. PharmaceuticalsACTIVE
63539-236Cibinqo Non-Proprietary Name: AbrocitinibTablet, Film CoatedOralU.s. PharmaceuticalsACTIVE
63539-336Cibinqo Non-Proprietary Name: AbrocitinibTablet, Film CoatedOralU.s. PharmaceuticalsACTIVE
63539-436Cibinqo Non-Proprietary Name: AbrocitinibTablet, Film CoatedOralU.s. PharmaceuticalsACTIVE
63539-501Xeljanz XRNon-Proprietary Name: TofacitinibTablet, Extended ReleaseOralU.s. PharmaceuticalsACTIVE
63539-502Xeljanz XRNon-Proprietary Name: TofacitinibTablet, Extended ReleaseOralU.s. PharmaceuticalsACTIVE